Pharmaceutical Business review

ADMEcell signs agreement with Advancell

According to ADMEcell, the CacoReady system is a new tool designed to optimize the time and costs of evaluating the intestinal absorption of compounds. The kit has been designed to provide a ready-to-use user-friendly kit and suitable for high-throughput automated procedures. It provides users with the differentiated Caco-2 barrier (21-day system), plated on 24- or 96-transwell plates.

Sandy Koshkin, president of ADMEcell, said: “This kit with differentiated Caco-2 cell barriers is an innovation that is being offered in North America for the first time. Our customers gain considerable savings of both cost and time.”